Abstract 5584: PHY906(YIV-906), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Immune checkpoint blockade therapy: anti-PDL1, anti-PD1, anti-PD1/CTLA4 against melanoma
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
Keyword(s):
2020 ◽